SEC CIK 1581992
Goddard Glenn
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| NTLAview stock → | 69,213 | 2024-03-01 |
| AGIOview stock → | 0 | 2015-09-24 |
Position History — NTLA
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — NTLA
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2024-03-01 | Grant / award (derivative) | 41,316 | $0.00 | 41,316 |
| 2024-03-01 | Grant / award | 28,628 | $0.00 | 69,213 |
| 2024-01-03 | Open-market sale | 5,365 | $29.46 | 40,585 |
| 2024-01-01 | Option exercise (derivative) | 3,062 | $0.00 | 3,064 |
| 2024-01-01 | Option exercise | 3,062 | — | 45,950 |
| 2023-03-01 | Grant / award (derivative) | 38,834 | $0.00 | 38,834 |
| 2023-03-01 | Grant / award | 27,484 | $0.00 | 42,888 |
| 2023-01-04 | Open-market sale | 2,427 | $37.21 | 15,404 |
| 2023-01-01 | Option exercise (derivative) | 3,062 | $0.00 | 6,126 |
| 2023-01-01 | Option exercise | 3,062 | — | 17,831 |
| 2022-03-01 | Grant / award (derivative) | 12,720 | $0.00 | 12,720 |
| 2022-03-01 | Grant / award | 12,720 | $0.00 | 14,769 |
| 2022-03-01 | Grant / award (derivative) | 18,600 | $0.00 | 18,600 |
| 2022-01-01 | Option exercise (derivative) | 3,062 | $0.00 | 9,188 |
| 2022-01-01 | Option exercise | 3,062 | — | 3,062 |
| 2022-01-01 | Open-market sale | 1,013 | $112.24 | 2,049 |
| 2021-09-07 | Option exercise (derivative) | 3,482 | $0.00 | 12,451 |
| 2021-09-07 | Open-market sale | 3,482 | $180.12 | 0 |
| 2021-09-07 | Option exercise | 3,482 | $14.58 | 3,482 |
| 2021-08-31 | Option exercise (derivative) | 1,817 | $0.00 | 15,933 |
| 2021-08-31 | Option exercise (derivative) | 22,983 | $0.00 | 41,817 |
| 2021-08-31 | Option exercise | 1,817 | $14.58 | 24,800 |
| 2021-08-31 | Option exercise | 22,983 | $19.27 | 22,983 |
| 2021-08-31 | Open-market sale | 24,800 | $160.22 | 0 |
| 2021-08-30 | Option exercise (derivative) | 5,200 | $0.00 | 64,800 |
| 2021-08-30 | Open-market sale | 496 | $157.33 | 900 |
| 2021-08-30 | Open-market sale | 300 | $160.84 | 0 |
| 2021-08-30 | Open-market sale | 300 | $159.53 | 300 |
| 2021-08-30 | Open-market sale | 300 | $158.42 | 600 |
| 2021-08-30 | Open-market sale | 300 | $156.10 | 1,396 |
| 2021-08-30 | Open-market sale | 1,700 | $155.29 | 1,696 |
| 2021-08-30 | Open-market sale | 1,100 | $154.29 | 3,396 |
| 2021-08-30 | Open-market sale | 704 | $153.22 | 4,496 |
| 2021-08-30 | Option exercise | 5,200 | $19.27 | 5,200 |
| 2021-08-05 | Option exercise (derivative) | 20,000 | $0.00 | 70,000 |
| 2021-08-05 | Open-market sale | 530 | $152.13 | 0 |
| 2021-08-05 | Open-market sale | 9,568 | $151.41 | 530 |
| 2021-08-05 | Option exercise | 20,000 | $19.27 | 20,000 |
| 2021-08-05 | Open-market sale | 9,902 | $150.65 | 10,098 |
| 2021-03-03 | Grant / award (derivative) | 73,500 | $0.00 | 73,500 |
| 2021-03-03 | Grant / award (derivative) | 12,250 | $0.00 | 12,250 |
| 2020-03-02 | Grant / award (derivative) | 125,000 | $0.00 | 125,000 |
| 2018-12-18 | Grant / award (derivative) | 17,750 | $0.00 | 17,750 |
| 2018-11-01 | Grant / award (derivative) | 90,000 | $0.00 | 90,000 |
| 2018-11-01 | Grant / award (derivative) | 90,000 | $0.00 | 90,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.